Integrative Chiropractic Care and Modern Solutions to Reduce OUD

Discover how integrative chiropractic care for OUD can provide a comprehensive approach to managing opioid use disorder safely.

How Chiropractic Care Reduces the Musculoskeletal Drivers of Opioid Use Disorder

In this educational post, I explain how opioid use disorder (OUD) and musculoskeletal pain reinforce each other, and how integrative chiropractic care can interrupt that loop. I am Dr. Alexander Jimenez, DC, APRN, FNP-BC. At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, I work with our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD, to combine spinal and soft-tissue care, rehabilitation, functional medicine, and medical oversight.

Chiropractic care does not replace medications for opioid use disorder (MOUD). Buprenorphine and methadone remain the treatments with the strongest mortality benefit. What chiropractic care can do is change the body systems that keep people reaching for opioids: stiff and irritated joints, overloaded muscles, altered movement, heightened pain sensitivity, poor sleep, and an overactive stress response. Large observational studies associate earlier chiropractic care for spine pain with lower odds of receiving a prescription opioid and, in one matched cohort, a lower observed risk of an OUD diagnosis. Those findings are associations, not proof that an adjustment cures addiction. They support a practical claim I see in clinic: when we restore motion and load tolerance, pain becomes a less dominant driver of use.

Key takeaways

• Musculoskeletal pain is both a common on-ramp to prescription opioids and a relapse trigger after OUD is established. Treating the joint, muscle, and movement problem is part of treating the opioid problem.
• Spinal joint dysfunction, myofascial overload, and guarded movement increase nociceptive input. Repeated input can sensitize the dorsal horn and cortex, so ordinary loads feel dangerous.
• High-velocity, low-amplitude adjustments and graded mobilization stimulate joint and muscle mechanoreceptors. The best-supported analgesic pathway is descending inhibition using serotonin and noradrenaline, not a new opioid prescription (Skyba et al., 2003; Bialosky et al., 2009).
• People with noncancer spine pain who receive chiropractic care have lower odds of filling an opioid prescription. A 2025 systematic review estimated 64% lower odds versus usual medical care alone, with a larger association when care started within 30 days, at very low certainty (Emary et al., 2025).
• In a matched cohort of adults with new low back pain, initial spinal manipulative therapy by a chiropractor was associated with a lower two-year risk of an OUD diagnosis than initial ibuprofen (0.24% versus 1.51%; risk ratio 0.20). Residual confounding remains possible (Trager, Cupler, et al., 2025).
• In my El Paso practice, the recurring pattern is thoracolumbar stiffness, hip abductor weakness, and chest-dominant breathing alongside chronic pain and opioid exposure. Restoring those three often lowers pain scores, improves sleep, and makes MOUD easier to stay on (Jimenez, 2026a, 2026b).
• Naloxone, syringe services, and same-day buprenorphine access still come first. No one can rehabilitate a joint if they do not survive the week.

About our integrated care team

I am a Doctor of Chiropractic and a board-certified Family Nurse Practitioner, with additional certification in functional medicine (CFMP, IFMCP) and chiropractic sports care (CCST). My clinical work sits at the intersection of injury, chronic pain, rehabilitation, and addiction-informed primary care. I describe that work on Health Coach Clinic and on LinkedIn.

Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine and has more than 40 years of experience. She is our Medical Director and Collaborative Physician (NPI 1164426749; Texas MD license J2933). She reviews cardiopulmonary and hepatic risk, medication interactions, infectious disease screening, and MOUD monitoring. Chiropractic care in this model is not freestanding addiction treatment. It is musculoskeletal care delivered inside a physician-directed plan.

Why musculoskeletal pain feeds opioid use

Most people who develop OUD did not start by seeking euphoria. Many started with a back, neck, shoulder, or joint injury, a prescription that worked for a while, and a nervous system that adapted. National Survey on Drug Use and Health estimates for 2024 found that 4.8 million people aged 12 or older had a past-year opioid use disorder, and only 17% of them (about 818,000 people) received MOUD (Substance Abuse and Mental Health Services Administration [SAMHSA], 2025). Provisional mortality data from the National Center for Health Statistics estimated 69,973 drug overdose deaths in 2025, down from 81,313 in 2024. Opioid-involved deaths fell from an estimated 55,296 to 44,564 (National Center for Health Statistics, 2026).

The clinical bridge is pain plus a sensitized musculoskeletal system. A painful segment keeps firing nociceptors. Muscles around that segment guard, fatigue, and develop trigger points. The person moves less, load tolerance drops, and even ordinary tasks hurt more. Opioids briefly dampen that signal, then tolerance, withdrawal, and opioid-induced hyperalgesia make the same tissues feel worse (Lee et al., 2011). Use continues “not to get high, but not to feel sick,” and also not to feel the back seize on the way to work. If we only swap one molecule for another and leave the stiff segment, weak hip, and guarded gait alone, we leave a daily relapse cue in the body.

How chiropractic care affects the musculoskeletal system

Chiropractic care is a mechanical input with a neurological output. Bialosky and colleagues (2009) described the working model: a force applied to a joint or soft tissue starts a cascade in the peripheral and central nervous systems, and those neurophysiological responses, not a permanent “realignment,” account for most clinical change.

Spinal and peripheral joints are packed with mechanoreceptors. When a segment stops moving well, nociceptive input becomes relatively louder. A specific adjustment or mobilization restores accessory motion and fires large-diameter A-beta afferents. Those fibers inhibit nociceptive transmission in the dorsal horn. Patients usually describe this as the joint “letting go” and the pain dropping before strength has had time to change. Strength changes come later, from exercise. The first change is sensory.

Opioid-related pain is rarely only a disc or a facet. Chronic use, poor sleep, low protein intake, and long periods of guarding produce dense, ischemic muscle. Trigger points in the lumbar erectors, quadratus lumborum, gluteus medius, piriformis, upper trapezius, and suboccipitals refer pain that patients often call “the same pain the pills used to cover.” Soft-tissue work lowers the resting tone that keeps compressing the joint we just mobilized. Without that step, the adjustment is temporary.

Animal work on joint manipulation found that spinal serotonin and alpha-2 adrenergic antagonists blocked the anti-hyperalgesic effect, while opioid or GABA-A antagonists did not (Skyba et al., 2003). Manual therapy appears to recruit descending monoamine pathways, rather than flooding mu-opioid receptors the way heroin, fentanyl, or oxycodone do (Vigotsky & Bruhns, 2015; Bialosky et al., 2009). That is why chiropractic care can reduce pain in a person on buprenorphine without competing for the receptor that medication is stabilizing.

Pain also changes motor control. People with persistent low back pain often stiffen the thoracolumbar junction, underuse the gluteal muscles, and breathe with the neck and chest. Rehabilitation rebuilds diaphragmatic breathing, hip hinge, gluteal endurance, scapular control, then graded loading. On LinkedIn, I describe the same sequence as turn down the fire, then fix the load. A spinal injury does not remodel in a nutritional vacuum.

Long-term opioid exposure can make the same stimulus hurt more through NMDA activation, glial cytokine release, and a shift in descending modulation (Lee et al., 2011). Chiropractic care does not reverse receptor tolerance. It can reduce the peripheral drivers that keep feeding a sensitized cord: hypomobile segments, ischemic muscle, and fear-driven stillness (Moseley & Butler, 2015).

Musculoskeletal comorbidities of OUD

The lumbar spine, hips, and thoracic cage share load. If the hips do not extend, the lumbar facets do. Patients with long opioid exposure often present with a flat lumbar curve, a rigid thoracolumbar junction, and hips that will not internally rotate. Adjustments restore the missing accessory motion so the neighboring region can stop compensating.

Withdrawal is a hyperadrenergic state. Muscle tone rises, sleep fragments, and people stop loading tissue. Soft-tissue work plus graded strengthening reverses that faster than either alone. Rib and thoracic mobilization, plus a short diaphragmatic drill, often drop morning spasm before we talk about the rest of the day.

A large share of OUD histories begin with a work injury, a collision, or a sports sprain. Pain catastrophizing and fear of movement are relapse triggers (Sullivan et al., 1995). The most useful relapse prevention is a written plan for the next flare (Foster et al., 2018).

On the functional medicine side of Health Coach Clinic, I look for the substrate that makes musculoskeletal pain louder: poor glycemic control, low vitamin D, low protein intake, iron deficiency, thyroid dysfunction, and short sleep. These do not cause OUD. They make every nociceptive signal harder to inhibit, and they slow tissue repair. Numbness, burning, and balance loss from neuropathy change gait and overload the lumbar spine and knees. Chiropractic care does not regenerate a nerve. It can restore the joint motion and hip strategy that keep a neuropathic gait from creating a second pain generator.

What the evidence actually shows

For noncancer back and neck pain, major guidelines recommend nonopioid and nonpharmacologic options, including spinal manipulation, exercise, and education, ahead of opioids (Qaseem et al., 2017).

A systematic review of 2 randomized trials and 18 cohort studies found very low-certainty evidence that chiropractic care for noncancer spine pain was associated with 64% lower odds of receiving a prescription opioid than usual medical care alone (odds ratio 0.36; 95% CI 0.25 to 0.52). Starting care within 30 days had a stronger association (odds ratio 0.33) than later care (odds ratio 0.73) (Emary et al., 2025).

In a matched cohort of opioid-naive adults with new low back pain, initial spinal manipulative therapy by a chiropractor was associated with a lower two-year incidence of an OUD diagnosis than initial ibuprofen: 0.24% versus 1.51% (risk ratio 0.20; 95% CI 0.15 to 0.28). Long-term opioid use and any opioid prescription were also lower (Trager, Cupler, et al., 2025). A related sciatica cohort found a lower one-year risk of an opioid-related adverse event (risk ratio 0.29), largely explained by fewer opioid prescriptions (Trager, Cupler, Srinivasan, et al., 2025). These are associations. They do not prove that manipulation treats addiction. Mortality reduction in OUD still belongs to MOUD (Sordo et al., 2017; National Academies of Sciences, Engineering, and Medicine, 2019).

Clinical observations from practice

These are patterns from my El Paso panels, not trial endpoints.

• The sentence I hear most often is a version of “I don’t use to feel high anymore. I use so I don’t feel sick or in pain.” Until the pain half of that sentence has a credible answer, abstinence talk lands as a threat.
• Patients on buprenorphine who use split dosing and also start graded hip and trunk work often report better daytime function, fewer cravings tied to evening spasm, and less pain variability.
• Microinduction has been the practical bridge for patients with heavy fentanyl exposure or a prior precipitated withdrawal (Hammig et al., 2016).
• The mechanical triad I correct first is a stiff thoracolumbar junction, a weak gluteus medius, and a breath that never reaches the diaphragm. When those three change, sleep and walking tolerance usually change before the opioid dose does.
• Coordinating wound care and safer-use supplies while we treat the spine builds trust faster than a lecture.
• Adjustments without a flare plan do not hold. Adjustments plus pacing, stabilization, and a written plan for the next bad day reduce the catastrophizing that used to send people back to a bag or a leftover bottle.
• Functional labs earn their place when pain is disproportionate to imaging. Low vitamin D, anemia, and erratic glucose do not explain a disc herniation, but they explain why rehab stalls (Jimenez, 2026a).

Where MOUD fits

DSM-5-TR defines OUD as a problematic pattern of opioid use causing impairment or distress within 12 months, with at least 2 of 11 criteria. Severity is mild (2 to 3), moderate (4 to 5), or severe (6 or more) (American Psychiatric Association, 2022). Methadone is dispensed through opioid treatment programs (Mattick et al., 2014). Buprenorphine is a partial agonist with a ceiling on respiratory depression, and office-based prescribing no longer requires an X-waiver (SAMHSA, 2024). Extended-release naltrexone is an option after full detoxification (Lee et al., 2016). I do not stop buprenorphine because a patient used it. I reassess the dose, the pain driver, and the social stressor.

Harm reduction still comes first. Prescribe and practice naloxone (Clark et al., 2014). Syringe service programs remain a practical source of wound supplies and linkage to testing (Centers for Disease Control and Prevention, 2024). Xylazine-associated wounds need nonjudgmental care, and MOUD should continue through that treatment (National Institute on Drug Abuse, 2024). Motivational interviewing is the conversation style that holds this together (Miller & Rollnick, 2013).

A typical first month is naloxone and a buprenorphine discussion, a movement screen, thoracic and lumbar mobilization as tolerated, hip and diaphragmatic retraining, infectious-disease screening, and a written flare plan. Pain elimination is not the promise. A smaller pain signal, and a body that can carry ordinary life, is.

OUD is maintained by pharmacology and by a musculoskeletal system that has learned to hurt. MOUD stabilizes the receptor and saves lives. Chiropractic care stabilizes the joint, the muscle, and the movement pattern that keep sending a pain signal into that receptor system.

References

• American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). doi.org/10.1176/appi.books.9780890425787
• Bialosky, J. E., Bishop, M. D., Price, D. D., Robinson, M. E., & George, S. Z. (2009). The mechanisms of manual therapy in the treatment of musculoskeletal pain: A comprehensive model. Manual Therapy, 14(5), 531-538. doi.org/10.1016/j.math.2008.09.001
• Centers for Disease Control and Prevention. (2024). Syringe services programs (SSPs). www.cdc.gov/syringe-services-programs/php/index.html
• Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. American Journal of Public Health, 104(8), e43-e51. doi.org/10.2105/AJPH.2014.301903https://doi.org/10.2105/AJPH.2014.301903
• Emary, P. C., Brown, A. L., Oremus, M., Mbuagbaw, L., Cameron, D. F., DiDonato, J., & Busse, J. W. (2025). Impact of chiropractic care on opioid use for noncancer spine pain: Systematic review and meta-analysis. PAIN Reports, 11(1), e1374. doi.org/10.1097/PR9.0000000000001374
• Foster, N. E., Anema, J. R., Cherkin, D., Chou, R., Cohen, S. P., Gross, D. P., Ferreira, P. H., Fritz, J. M., Koes, B. W., Peul, W., Turner, J. A., & Maher, C. G. (2018). Prevention and treatment of low back pain: Evidence, challenges, and promising directions. The Lancet, 391(10137), 2368-2383. doi.org/10.1016/S0140-6736(18)30489-6
• Hammig, R., Kemter, A., Strasser, J., von Bardeleben, U., Gugger, B., Walter, M., Dursteler, K. M., & Vogel, M. (2016). Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: The Bernese method. Substance Abuse and Rehabilitation, 7, 99-105. doi.org/10.2147/SAR.S109919
• Jimenez, A. (2026a). Health Coach Clinic. healthcoach.clinic/
• Jimenez, A. (2026b). Dr. Alexander Jimenez, DC, APRN, FNP-BC. LinkedIn. www.linkedin.com/in/dralexjimenez/
• Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., Jr., Wilson, D., McDonald, R., Rotrosen, J., Gourevitch, M. N., Gordon, M., Fishman, M., Chen, D. T., Bonnie, R. J., Cornish, J. W., Murphy, S. M., & O’Brien, C. P. (2016). Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. The New England Journal of Medicine, 374(13), 1232-1242. doi.org/10.1056/NEJMoa1505409
• Lee, M., Silverman, S., Hansen, H., Patel, V., & Manchikanti, L. (2011). A comprehensive review of opioid-induced hyperalgesia. Pain Physician, 14(2), 145-161.
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2014(2), Article CD002207. doi.org/10.1002/14651858.CD002207.pub4
• Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). The Guilford Press.
• Moseley, G. L., & Butler, D. S. (2015). Fifteen years of explaining pain: The past, present, and future. The Journal of Pain, 16(9), 807-813. doi.org/10.1016/j.jpain.2015.05.005
• National Academies of Sciences, Engineering, and Medicine. (2019). Medications for opioid use disorder save lives. National Academies Press. doi.org/10.17226/25310
• National Center for Health Statistics. (2026, May 13). U.S. overdose deaths decrease for third consecutive year in 2025. Centers for Disease Control and Prevention. www.cdc.gov/nchs/pressroom/releases/20260513.html
• National Institute on Drug Abuse. (2024). Xylazine. nida.nih.gov/research-topics/xylazine
• Qaseem, A., Wilt, T. J., McLean, R. M., & Forciea, M. A. (2017). Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 166(7), 514-530. doi.org/10.7326/M16-2367
• Skyba, D. A., Radhakrishnan, R., Rohlwing, J. J., Wright, A., & Sluka, K. A. (2003). Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord. Pain, 106(1-2), 159-168. doi.org/10.1016/S0304-3959(03)00320-8
• Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ, 357, Article j1550. doi.org/10.1136/bmj.j1550
• Substance Abuse and Mental Health Services Administration. (2024). Buprenorphine. www.samhsa.gov/substance-use/treatment/options/buprenorphine
• Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality. www.samhsa.gov/data/sites/default/files/reports/rpt56287/2024-nsduh-annual-national/2024-nsduh-annual-national-html-071425-edited/2024-nsduh-annual-national.htm
• Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995). The Pain Catastrophizing Scale: Development and validation. Psychological Assessment, 7(4), 524-532. doi.org/10.1037/1040-3590.7.4.524
• Trager, R. J., Cupler, Z. A., Gliedt, J. A., Fischer, R. A., Srinivasan, R., & Thorfinnson, H. (2025). Association between spinal manipulative therapy for low back pain with or without sciatica and opioid use disorder: A retrospective cohort study. Health Science Reports, 8(9), e71267. doi.org/10.1002/hsr2.71267
• Trager, R. J., Cupler, Z. A., Srinivasan, R., Harper, E. G., & Perez, J. A. (2025). Association between chiropractic spinal manipulation for sciatica and opioid-related adverse events: A retrospective cohort study. PLOS ONE, 20(1), e0317663. doi.org/10.1371/journal.pone.0317663
• Vigotsky, A. D., & Bruhns, R. P. (2015). The role of descending modulation in manual therapy and its analgesic implications: A narrative review. Pain Research and Treatment, 2015, Article 292805. doi.org/10.1155/2015/292805

SEO tags

opioid use disorder, OUD, chiropractic care, spinal manipulation, musculoskeletal pain, low back pain, opioid-induced hyperalgesia, central sensitization, myofascial pain, descending inhibition, buprenorphine, methadone, naltrexone, MOUD, harm reduction, naloxone, fentanyl, xylazine, precipitated withdrawal, microinduction, motivational interviewing, DSM-5-TR, integrative chiropractic care, functional medicine, rehabilitation, injury care, kinesiophobia, pain catastrophizing, overdose prevention, El Paso, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alexander Jimenez, Dr. Maria Guadalupe Cardenas, personal injury, graded exposure, non-opioid pain care